F43.1 F43.2
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Traumatic event within the last three months AND traumarelated symptoms
Exclusion criteria
Exclusion criteria: Intake of benzodiazepines, steroids, opiates, neuroleptics, melatonine, beta-blockers, anti depressants, anti histamines, stimulants or over-the-counter sleep medication. Lifetime diagnosis of schizophrenia, bipolar disorder or more than 2 depressive episodes Alcohol or substance abuse in the last year IQ < 80 systemic, neurological illness acute suicidal tendencies non-fluency in german shift work or intercontonental flights in the last 30 days sleep apnea
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Posttraumatic symptoms are assessed with questionnaires (PCL-5, Weathers et al., 2013; PTCI, Foa et al., 1999). Sleep quality is measured subjectively with sleep diaries and the PSQI (Buysse et al., 1989). Symptoms are measured prior to the intervention as well as 10 weeks and six months after inclusion in the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Additionally, anxiety (GAD-7, Spitzer et al., 2006), depression (QIDS-SR16, Rush et al., 2003) and life quality (WHODAS 2.0) are measured at all three assessment points. | — |
Countries
Germany
Contacts
Zentrum für Integrative PsychiatrieKlinik für Psychiatrie und PsychotherapieTranslational Psychiatry Unit, Research Group Sleep and Mental Health;Zentrum für Integrative PsychiatrieKlinik für Psychiatrie und PsychotherapieTranslational Psychiatry Unit, Research Group Sleep and Mental Health